Back to Journals » Drug Design, Development and Therapy » Volume 6

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach

Total article views   HTML views PDF downloads Totals
16,667 Dovepress* 12,809+ 2,809 15,618
PubMed Central* 3,858 1,592 5,450
Totals 16,667 4,401 21,068
*Since 19 July 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
11 0 0 0 2 9

View citations on PubMed Central and Google Scholar